Characterization of neuroblastoma cell lines with ATRX multi-exon deletions. by Michael R. van Gerven (16764526)

Fig 4 - by Torsten Schober (20485754)

Participant inclusion flowchart. by Shakila Meshkat (12360623)

“…In both unadjusted and adjusted models, participants with depressive symptoms had lower odds of FS (aOR = 0.347, 95% CI: 0.307,0.391, p<0.001). Moreover, in both unadjusted and adjusted models, for each 1-point increase in cognitive-affective (aOR = 0.850, 95% CI = 0.836,0.864, p <0.001) and somatic symptoms (aOR = 0.847, 95% CI = 0.831,0.863, p <0.001), odds of high FS decreased correspondingly. …”

Demographics of study sample. by Shakila Meshkat (12360623)

“…In both unadjusted and adjusted models, participants with depressive symptoms had lower odds of FS (aOR = 0.347, 95% CI: 0.307,0.391, p<0.001). Moreover, in both unadjusted and adjusted models, for each 1-point increase in cognitive-affective (aOR = 0.850, 95% CI = 0.836,0.864, p <0.001) and somatic symptoms (aOR = 0.847, 95% CI = 0.831,0.863, p <0.001), odds of high FS decreased correspondingly. …”

Antibodies used for western blotting and for immune fluorescence. by Michael R. van Gerven (16764526)

Sequences of sgRNAs used to make isogenic knock-out and ATRX MEDs. by Michael R. van Gerven (16764526)

All media and their components used for culturing the cell lines/organoids and isogenic clones. by Michael R. van Gerven (16764526)

Results for four illustrative latent topics specified by a 50-topic CGC LDA model estimated from a corpus with 5,225 documents and a vocabulary of 28,971 words by DM Blei (19075)

Fig 6 - by Torsten Schober (20485754)

Gene set enrichment analysis (GSEA) reveals two opposing expression patterns within <i>ATRX</i> aberrant neuroblastoma related to ribosome biogenesis. by Michael R. van Gerven (16764526)

Primers used for cloning homology arm plasmids and PiggyBac doxycycline inducible <i>ATRX</i> wild-type plasmid. by Michael R. van Gerven (16764526)

The number of significantly downregulated and upregulated differentially expressed genes for all 8 analyses with an p-adjusted value of 0.05. by Michael R. van Gerven (16764526)

DataSheet7_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”

DataSheet6_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”

DataSheet4_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”

DataSheet1_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.PDF by Sabrina R. Mackinnon (12496324)

“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”

DataSheet3_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”

DataSheet2_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”

Scopoli’s shearwater and the Yellow-legged mean egg volume synchrony results. by Ana Payo-Payo (2911796)

“…<p>a) Mean egg volume 95% confidence intervals (grey) of the Scopoli’s shearwater and the Yellow-legged gull (black) breeding at Dragonera Natural Park (2002–2019, Spain). …”

Model sensitivity analysis to parameters: <i>k</i>_5,<i>P</i>, <i>K</i>_<i>a</i>, <i>K</i>_<i>PLC</i>, <i>V</i>_<i>SERCA</i> and <i>β</i>. by Dharsan K. Soundarrajan (11632145)

“…<b>(D)</b> Decreased <i>V</i>_<i>SERCA</i> (BV of 0.9 μM s^-1) increased frequency and duration of the Ca²⁺ signal to the point of observing constant activity, whereas increased <i>V</i>_<i>SERCA</i> decreased frequency to the point of loss of signal in a 60 minute simulation. …”